Literature DB >> 30893703

Association between Primary Open-Angle Glaucoma and Cognitive Impairment as Measured by the Montreal Cognitive Assessment.

Makayla McCoskey1, Victoria Addis1, Kendall Goodyear1, Prithvi S Sankar1, Gui-Shuang Ying2, Yinxi Yu2, Rebecca Salowe1, Qi N Cui1, Eydie Miller-Ellis1, Maureen Maguire2, Joan M O Apos Brien3.   

Abstract

BACKGROUND: It is currently unclear whether primary open-angle glaucoma (POAG) affects neurological functions outside of vision, such as cognition.
OBJECTIVE: This study examined the association between POAG and cognitive impairment in African Americans.
METHODS: Masked interviewers administered the Montreal Cognitive Assessment (MoCA) to patients enrolled in the Primary Open-Angle African American Glaucoma Genetics (POAAGG) study at the Scheie Eye Institute. Cases were further assessed for retinal nerve fiber layer (RNFL) thickness and visual field (VF) loss. Univariate and multivariate linear regression analyses were performed to compare mean MoCA score between cases and controls and to assess the association between POAG severity and MoCA score.
RESULTS: A total of 137 patients completed the MoCA, including 70 cases and 67 controls. The mean age ± SD was 68.7 ± 11.2 years for cases and 65.7 ± 10.4 years for controls (p = 0.11). The mean MoCA total score (out of 30 points) was 20.3 among POAG cases and 21.3 among controls (mean difference = -1.03, 95% confidence interval, CI = -2.54 to 0.48, p = 0.18). After adjusting for age, gender, education level, diabetes, hypertension, and smoking status, the mean difference in the MoCA total score between cases and controls was -0.64 (95% CI = -1.72 to 0.45, p = 0.25). Among cases, more VF loss was associated with lower total MoCA score for mean deviation (adjusted linear trend p = 0.02) and VF index (adjusted linear trend p = 0.03). There was no significant association between average RNFL thickness and total MoCA score.
CONCLUSIONS: POAG cases and controls had similar neurocognitive function as measured by the MoCA. Among POAG cases, worse VF loss was associated with lower MoCA. Future studies are needed to further elucidate the clinical effect of neuropathy in POAG.
© 2019 S. Karger AG, Basel.

Entities:  

Keywords:  African American; Cognitive impairment; Dementia; Glaucoma; Montreal Cognitive Assessment; Vision

Mesh:

Year:  2019        PMID: 30893703      PMCID: PMC6459693          DOI: 10.1159/000496233

Source DB:  PubMed          Journal:  Neurodegener Dis        ISSN: 1660-2854            Impact factor:   2.977


  27 in total

Review 1.  Primary open-angle glaucoma.

Authors:  Robert N Weinreb; Peng Tee Khaw
Journal:  Lancet       Date:  2004-05-22       Impact factor: 79.321

2.  Longitudinal Associations Between Visual Impairment and Cognitive Functioning: The Salisbury Eye Evaluation Study.

Authors:  D Diane Zheng; Bonnielin K Swenor; Sharon L Christ; Sheila K West; Byron L Lam; David J Lee
Journal:  JAMA Ophthalmol       Date:  2018-09-01       Impact factor: 7.389

3.  The Montreal Cognitive Assessment, MoCA: a brief screening tool for mild cognitive impairment.

Authors:  Ziad S Nasreddine; Natalie A Phillips; Valérie Bédirian; Simon Charbonneau; Victor Whitehead; Isabelle Collin; Jeffrey L Cummings; Howard Chertkow
Journal:  J Am Geriatr Soc       Date:  2005-04       Impact factor: 5.562

4.  Genetic risk of primary open-angle glaucoma. Population-based familial aggregation study.

Authors:  R C Wolfs; C C Klaver; R S Ramrattan; C M van Duijn; A Hofman; P T de Jong
Journal:  Arch Ophthalmol       Date:  1998-12

5.  Is there a link between open-angle glaucoma and dementia? The Three-City-Alienor cohort.

Authors:  Catherine Helmer; Florence Malet; Marie-Bénédicte Rougier; Cédric Schweitzer; Joseph Colin; Marie-Noëlle Delyfer; Jean-François Korobelnik; Pascale Barberger-Gateau; Jean-François Dartigues; Cécile Delcourt
Journal:  Ann Neurol       Date:  2013-09-10       Impact factor: 10.422

6.  Cognitive impairment in the Age-Related Eye Disease Study: AREDS report no. 16.

Authors:  Traci E Clemons; Molly W Rankin; Wendy L McBee
Journal:  Arch Ophthalmol       Date:  2006-04

7.  Cognitive evaluation of patients with glaucoma and its comparison with individuals with Alzheimer's disease.

Authors:  Stephanie Toledo Piza Maurano; Delson José da Silva; Marcos P Ávila; Leopoldo Magacho
Journal:  Int Ophthalmol       Date:  2017-07-25       Impact factor: 2.031

Review 8.  Effects of retinal ganglion cell loss on magno-, parvo-, koniocellular pathways in the lateral geniculate nucleus and visual cortex in glaucoma.

Authors:  Yeni H Yücel; Qiang Zhang; Robert N Weinreb; Paul L Kaufman; Neeru Gupta
Journal:  Prog Retin Eye Res       Date:  2003-07       Impact factor: 21.198

9.  The benefit of early trabeculectomy versus conventional management in primary open angle glaucoma relative to severity of disease.

Authors:  J L Jay; D Allan
Journal:  Eye (Lond)       Date:  1989       Impact factor: 3.775

Review 10.  Neuroprotective therapies for glaucoma.

Authors:  Wei Song; Ping Huang; Chun Zhang
Journal:  Drug Des Devel Ther       Date:  2015-03-11       Impact factor: 4.162

View more
  4 in total

Review 1.  Glaucoma as Neurodegeneration in the Brain.

Authors:  Jane W Chan; Noel C Y Chan; Alfredo A Sadun
Journal:  Eye Brain       Date:  2021-01-18

2.  Cognitive Performance on the Montreal Cognitive Assessment Test and Retinal Structural and Functional Measures in Glaucoma.

Authors:  Solmaz Bastani Viarsagh; Min Er Zhang; Sahar Shariflou; Ashish Agar; S Mojtaba Golzan
Journal:  J Clin Med       Date:  2022-08-30       Impact factor: 4.964

3.  Association between cognitive performance and self-reported glaucoma in middle-aged and older adults: a cross-sectional analysis of ELSA-Brasil.

Authors:  K S Vidal; C K Suemoto; A B Moreno; B Duncan; M I Schmidt; M Maestri; S M Barreto; P A Lotufo; L Bertola; I M Bensenor; A R Brunoni
Journal:  Braz J Med Biol Res       Date:  2020-10-30       Impact factor: 2.590

4.  Changes in retinal multilayer thickness and vascular network of patients with Alzheimer's disease.

Authors:  Xi Mei; Conglong Qiu; Qi Zhou; Zhongming Chen; Yang Chen; Zemin Xu; Chenjun Zou
Journal:  Biomed Eng Online       Date:  2021-10-03       Impact factor: 2.819

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.